First Time Loading...

Brooks Laboratories Ltd
NSE:BROOKS

Watchlist Manager
Brooks Laboratories Ltd Logo
Brooks Laboratories Ltd
NSE:BROOKS
Watchlist
Price: 81.15 INR 0.81%
Updated: Jun 4, 2024
Financials Section:
Income Statement Balance Sheet Cash Flow Statement

Balance Sheet

1.1B
-3%
Assets
Growth Rates:
1 Year
-49%
3 Years
-40%
5 Years
-37%
7 Years
-34%
10 Years
-26%
268.7m
-25%
Liabilities
Growth Rates:
1 Year
-79%
3 Years
-65%
5 Years
-54%
7 Years
-24%
10 Years
-20%
791.2m
+7%
Equity
Growth Rates:
1 Year
-1%
3 Years
-20%
5 Years
-29%
7 Years
-36%
10 Years
-28%

Balance Sheet Decomposition
Brooks Laboratories Ltd

1.1B
Assets
268.7m
Liabilities
1.1B
Assets
268.7m
Liabilities
Current Assets 304.2m
Cash & Short-Term Investments 10m
Receivables 157.5m
Other Current Assets 136.7m
Non-Current Assets 755.8m
Long-Term Investments 583.5m
PP&E 140.7m
Intangibles 1.4m
Other Non-Current Assets 30.2m
Current Liabilities 243.6m
Accounts Payable 167.4m
Other Current Liabilities 76.2m
Non-Current Liabilities 25.1m
Long-Term Debt 4.7m
Other Non-Current Liabilities 20.5m

Balance Sheet
Brooks Laboratories Ltd

Rotate your device to view
Balance Sheet
Currency: INR
Mar-2014 Mar-2015 Mar-2016 Mar-2017 Mar-2018 Mar-2019 Mar-2020 Mar-2021 Mar-2022 Mar-2023
Assets
Cash & Cash Equivalents
300
229
22
18
20
33
15
17
38
0
Cash
0
0
19
17
13
8
11
8
12
0
Cash Equivalents
300
229
4
1
7
25
4
9
26
0
Short-Term Investments
0
0
7
3
3
4
6
4
15
14
Total Receivables
187
229
183
107
102
114
156
137
177
128
Accounts Receivables
165
193
183
107
102
114
156
137
177
128
Other Receivables
22
36
0
0
0
0
0
0
0
0
Inventory
60
75
67
77
114
101
138
236
275
113
Other Current Assets
0
15
4
14
68
66
65
84
107
22
Total Current Assets
547
548
283
219
307
317
379
478
612
276
PP&E Net
573
686
1 099
1 253
1 245
1 172
1 129
1 077
1 245
148
PP&E Gross
0
0
0
0
0
0
0
0
1 245
148
Accumulated Depreciation
0
0
0
0
0
0
0
0
324
283
Intangible Assets
0
0
0
0
0
4
3
7
6
2
Note Receivable
172
122
26
36
44
50
50
20
23
28
Long-Term Investments
0
0
25
23
21
21
17
14
15
642
Other Long-Term Assets
33
0
110
110
110
116
2
25
58
0
Total Assets
1 325
N/A
1 356
+2%
1 543
+14%
1 641
+6%
1 727
+5%
1 679
-3%
1 579
-6%
1 621
+3%
1 959
+21%
1 096
-44%
Liabilities
Accounts Payable
123
190
157
184
267
271
261
310
280
234
Accrued Liabilities
0
0
0
0
0
0
0
0
1
9
Short-Term Debt
1
5
53
22
85
145
126
136
111
57
Current Portion of Long-Term Debt
0
0
1
8
28
28
31
33
41
2
Other Current Liabilities
55
26
57
29
25
29
40
158
57
28
Total Current Liabilities
180
221
267
243
405
474
458
637
489
330
Long-Term Debt
0
0
3
107
166
139
119
144
101
6
Deferred Income Tax
16
13
0
0
0
0
0
32
0
0
Minority Interest
0
0
0
0
0
0
0
0
713
0
Other Liabilities
6
7
8
9
11
15
17
15
26
20
Total Liabilities
202
N/A
241
+20%
278
+15%
359
+29%
582
+62%
627
+8%
595
-5%
829
+39%
1 329
+60%
356
-73%
Equity
Common Stock
162
162
162
162
162
162
247
247
247
247
Retained Earnings
961
952
1 103
1 121
983
890
737
545
300
191
Additional Paid In Capital
0
0
0
0
0
0
0
0
680
680
Other Equity
0
0
0
0
0
0
0
0
4
4
Total Equity
1 123
N/A
1 114
-1%
1 265
+14%
1 283
+1%
1 145
-11%
1 052
-8%
984
-6%
792
-20%
631
-20%
740
+17%
Total Liabilities & Equity
1 325
N/A
1 356
+2%
1 543
+14%
1 641
+6%
1 727
+5%
1 679
-3%
1 579
-6%
1 621
+3%
1 959
+21%
1 096
-44%
Shares Outstanding
Common Shares Outstanding
19
19
19
19
19
19
25
25
25
25

See Also

Summary
BROOKS intrinsic value, competitors valuation, and company profile.
DCF Valuation
BROOKS stock valuation using Discount Cash Flow valuation method.
Relative Valuation
BROOKS stock valuation using valuation multiples.
Wall Street Estimates
BROOKS price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
BROOKS stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 143,500+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.